While the details of the deal have remained under wraps, a report from the Wall Street Journal revealed that approximately ...

Owlstone Medical has secured a $5 million equity investment and initial $1.5 million grant funding, committed by the Bill and ...

The new generative AI (GenAI) develops molecules from scratch in a way that precisely matches the protein they are intended ...

At Reuters Pharma USA last month, pharmaphorum editor-in-chief Jonah Comstock caught up with Meruno Perugini, president of ...

Fast forward to 2033, and the number of patients with end stage kidney disease requiring dialysis could increase by nearly ...

The San Francisco-based company has emerged from the incubators of ARCH Venture Partners and Foresite Labs with more than $1 ...

The cycle from hot to cold to hot again can take 10-15 years and a new technology may go through more than one such cycle (as ...

Ireland’s SynOx Therapeutics has completed a second-round financing, raising $75 million, as it prepares to take its drug for ...

Bristol-Myers Squibb has shored up manufacturing of its CAR-T therapies, tapping into capacity at contract manufacturer ...

Nexpovio (selinexor) – which is sold as Xpovio in some markets – is a first-in-class nuclear export XPO1 inhibitor that was ...

The healthcare industry is getting hit more and more frequently by ransomware attacks. Ben Hargreaves finds that hackers are ...